Xiuyu Tai

Array ( [id] => 5149519 [patent_doc_number] => 20070049579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Medicament having neovascularization promoting action' [patent_app_type] => utility [patent_app_number] => 11/366454 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2704 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049579.pdf [firstpage_image] =>[orig_patent_app_number] => 11366454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 54128 [patent_doc_number] => 07767682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Medicaments' [patent_app_type] => utility [patent_app_number] => 11/817523 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 6331 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767682.pdf [firstpage_image] =>[orig_patent_app_number] => 11817523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830201 [patent_doc_number] => 07399755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Formulations comprising multiple dietary and endogenously made antioxidants and B-vitamins and use of same' [patent_app_type] => utility [patent_app_number] => 11/357246 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7724 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399755.pdf [firstpage_image] =>[orig_patent_app_number] => 11357246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666640 [patent_doc_number] => 20060171990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Drug delivery materials made by sol/gel technology' [patent_app_type] => utility [patent_app_number] => 11/346983 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13261 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171990.pdf [firstpage_image] =>[orig_patent_app_number] => 11346983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700606 [patent_doc_number] => 20060217291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Radiosensitizer' [patent_app_type] => utility [patent_app_number] => 11/337557 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5271 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217291.pdf [firstpage_image] =>[orig_patent_app_number] => 11337557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777455 [patent_doc_number] => 20060106095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Therapeutic agent for renal failure' [patent_app_type] => utility [patent_app_number] => 11/319821 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5094 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106095.pdf [firstpage_image] =>[orig_patent_app_number] => 11319821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949917 [patent_doc_number] => 20080306043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar Disorders' [patent_app_type] => utility [patent_app_number] => 11/792850 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7866 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306043.pdf [firstpage_image] =>[orig_patent_app_number] => 11792850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866047 [patent_doc_number] => 20060100178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Dermal agent' [patent_app_type] => utility [patent_app_number] => 11/304577 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7465 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100178.pdf [firstpage_image] =>[orig_patent_app_number] => 11304577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866079 [patent_doc_number] => 20060100210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Methods for treatment of scleroderma' [patent_app_type] => utility [patent_app_number] => 11/304519 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16600 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100210.pdf [firstpage_image] =>[orig_patent_app_number] => 11304519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777417 [patent_doc_number] => 20060106057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Stabilization of quinapril using magnesium oxide' [patent_app_type] => utility [patent_app_number] => 11/313123 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4888 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106057.pdf [firstpage_image] =>[orig_patent_app_number] => 11313123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808349 [patent_doc_number] => 20060094704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Treatment of premature ejaculation' [patent_app_type] => utility [patent_app_number] => 11/292713 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7408 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094704.pdf [firstpage_image] =>[orig_patent_app_number] => 11292713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760817 [patent_doc_number] => 20060211762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Omega-3 fatty acids and dyslipidemic agent for lipid therapy' [patent_app_type] => utility [patent_app_number] => 11/284095 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8983 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211762.pdf [firstpage_image] =>[orig_patent_app_number] => 11284095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217170 [patent_doc_number] => 07612080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'GTPase inhibitors and use thereof for controlling platelet hyperactivity' [patent_app_type] => utility [patent_app_number] => 11/283556 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 20133 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612080.pdf [firstpage_image] =>[orig_patent_app_number] => 11283556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5029050 [patent_doc_number] => 20070270497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Agent For Recovery From Cerebral Fatigue' [patent_app_type] => utility [patent_app_number] => 11/718894 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3510 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270497.pdf [firstpage_image] =>[orig_patent_app_number] => 11718894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829151 [patent_doc_number] => 20060063781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Pharmaceutical composition for regeneration of cirrhotic liver' [patent_app_type] => utility [patent_app_number] => 11/261884 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5010 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063781.pdf [firstpage_image] =>[orig_patent_app_number] => 11261884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9454720 [patent_doc_number] => 08715724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Tabletting process' [patent_app_type] => utility [patent_app_number] => 11/666354 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6835 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11666354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743687 [patent_doc_number] => 20060089412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Pharmaceutical composition for the treatment of non-alcoholic fatty liver disease' [patent_app_type] => utility [patent_app_number] => 11/251932 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2300 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089412.pdf [firstpage_image] =>[orig_patent_app_number] => 11251932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131982 [patent_doc_number] => 07700653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Halogen-substituted aminodicarboxylic acid derivatives' [patent_app_type] => utility [patent_app_number] => 11/210131 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7339 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700653.pdf [firstpage_image] =>[orig_patent_app_number] => 11210131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5902525 [patent_doc_number] => 20060045905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Composition for repressing transformation growth factor beta' [patent_app_type] => utility [patent_app_number] => 11/209126 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4105 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20060045905.pdf [firstpage_image] =>[orig_patent_app_number] => 11209126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7244233 [patent_doc_number] => 20050271721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Carvedilol-hydrophilic solutions' [patent_app_type] => utility [patent_app_number] => 11/204614 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4435 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271721.pdf [firstpage_image] =>[orig_patent_app_number] => 11204614 [rel_patent_id] =>[rel_patent_doc_number] =>)